SGK1-Sensitive Regulation of Cyclin-Dependent Kinase Inhibitor 1B (p27) in Cardiomyocyte Hypertrophy

Background/Aims: The serum- and glucocorticoid-inducible kinase SGK1 participates in the orchestration of cardiac hypertrophy and remodeling. Signaling linking SGK1 activity to cardiac remodeling is, however, incompletely understood. SGK1 phosphorylation targets include cyclin-dependent kinase inhib...

Full description

Bibliographic Details
Main Authors: Jakob Voelkl, Tatsiana Castor, Katharina Musculus, Robert Viereck, Sobuj Mia, Martina Feger, Ioana Alesutan, Florian Lang
Format: Article
Language:English
Published: Cell Physiol Biochem Press GmbH & Co KG 2015-09-01
Series:Cellular Physiology and Biochemistry
Subjects:
Online Access:http://www.karger.com/Article/FullText/430380
_version_ 1818573668435886080
author Jakob Voelkl
Tatsiana Castor
Katharina Musculus
Robert Viereck
Sobuj Mia
Martina Feger
Ioana Alesutan
Florian Lang
author_facet Jakob Voelkl
Tatsiana Castor
Katharina Musculus
Robert Viereck
Sobuj Mia
Martina Feger
Ioana Alesutan
Florian Lang
author_sort Jakob Voelkl
collection DOAJ
description Background/Aims: The serum- and glucocorticoid-inducible kinase SGK1 participates in the orchestration of cardiac hypertrophy and remodeling. Signaling linking SGK1 activity to cardiac remodeling is, however, incompletely understood. SGK1 phosphorylation targets include cyclin-dependent kinase inhibitor 1B (p27), a protein which suppresses cardiac hypertrophy. The present study explored how effects of SGK1 on nuclear p27 localization might modulate the hypertrophic response in cardiomyocytes. Methods: Experiments were performed in HL-1 cardiomyocytes and in SGK1-deficient (sgk1-/-) and corresponding wild-type (sgk1+/+) mice following pressure overload by transverse aortic constriction (TAC). Transcript levels were quantified by RT-PCR, protein abundance by Western blotting and protein localization by confocal microscopy. Results: In HL-1 cardiomyocytes, overexpression of constitutively active SGK1 (SGK1S422D) but not of inactive SGK1 (SGK1K127N) increased significantly the cell size and transcript levels encoding Acta1, a molecular marker of hypertrophy. Those effects were paralleled by almost complete relocation of p27 in the cytoplasm. Treatment of HL-1 cardiomyocytes with isoproterenol was followed by up-regulation of SGK1 expression. Moreover, isoproterenol treatment stimulated the hypertrophic response and was followed by disappearance of p27 from the nuclei, effects prevented by the SGK1 inhibitor EMD638683. The effect of SGK1S422D overexpression on Acta1 mRNA levels was disrupted by overexpression of p27 and of the p27T197A mutant lacking the SGK1 phosphorylation site, but not of the phosphomimetic p27T197D mutant. In sgk1+/+ mice, TAC increased significantly SGK1 and Acta1 mRNA levels and decreased the nuclear to cytoplasmic protein ratio of p27 in cardiac tissue, effects blunted in the sgk1-/- mice. Conclusion: SGK1-induced hypertrophy of cardiomyocytes involves p27 phosphorylation at T197, which fosters cytoplasmic p27 localization.
first_indexed 2024-12-15T00:14:44Z
format Article
id doaj.art-94a5ff984c8e48c0a919ae037013231b
institution Directory Open Access Journal
issn 1015-8987
1421-9778
language English
last_indexed 2024-12-15T00:14:44Z
publishDate 2015-09-01
publisher Cell Physiol Biochem Press GmbH & Co KG
record_format Article
series Cellular Physiology and Biochemistry
spelling doaj.art-94a5ff984c8e48c0a919ae037013231b2022-12-21T22:42:29ZengCell Physiol Biochem Press GmbH & Co KGCellular Physiology and Biochemistry1015-89871421-97782015-09-0137260361410.1159/000430380430380SGK1-Sensitive Regulation of Cyclin-Dependent Kinase Inhibitor 1B (p27) in Cardiomyocyte HypertrophyJakob VoelklTatsiana CastorKatharina MusculusRobert ViereckSobuj MiaMartina FegerIoana AlesutanFlorian LangBackground/Aims: The serum- and glucocorticoid-inducible kinase SGK1 participates in the orchestration of cardiac hypertrophy and remodeling. Signaling linking SGK1 activity to cardiac remodeling is, however, incompletely understood. SGK1 phosphorylation targets include cyclin-dependent kinase inhibitor 1B (p27), a protein which suppresses cardiac hypertrophy. The present study explored how effects of SGK1 on nuclear p27 localization might modulate the hypertrophic response in cardiomyocytes. Methods: Experiments were performed in HL-1 cardiomyocytes and in SGK1-deficient (sgk1-/-) and corresponding wild-type (sgk1+/+) mice following pressure overload by transverse aortic constriction (TAC). Transcript levels were quantified by RT-PCR, protein abundance by Western blotting and protein localization by confocal microscopy. Results: In HL-1 cardiomyocytes, overexpression of constitutively active SGK1 (SGK1S422D) but not of inactive SGK1 (SGK1K127N) increased significantly the cell size and transcript levels encoding Acta1, a molecular marker of hypertrophy. Those effects were paralleled by almost complete relocation of p27 in the cytoplasm. Treatment of HL-1 cardiomyocytes with isoproterenol was followed by up-regulation of SGK1 expression. Moreover, isoproterenol treatment stimulated the hypertrophic response and was followed by disappearance of p27 from the nuclei, effects prevented by the SGK1 inhibitor EMD638683. The effect of SGK1S422D overexpression on Acta1 mRNA levels was disrupted by overexpression of p27 and of the p27T197A mutant lacking the SGK1 phosphorylation site, but not of the phosphomimetic p27T197D mutant. In sgk1+/+ mice, TAC increased significantly SGK1 and Acta1 mRNA levels and decreased the nuclear to cytoplasmic protein ratio of p27 in cardiac tissue, effects blunted in the sgk1-/- mice. Conclusion: SGK1-induced hypertrophy of cardiomyocytes involves p27 phosphorylation at T197, which fosters cytoplasmic p27 localization.http://www.karger.com/Article/FullText/430380p27Acta1IsoproterenolSGK1Cardiac hypertrophyHL-1 cardiomyocytes
spellingShingle Jakob Voelkl
Tatsiana Castor
Katharina Musculus
Robert Viereck
Sobuj Mia
Martina Feger
Ioana Alesutan
Florian Lang
SGK1-Sensitive Regulation of Cyclin-Dependent Kinase Inhibitor 1B (p27) in Cardiomyocyte Hypertrophy
Cellular Physiology and Biochemistry
p27
Acta1
Isoproterenol
SGK1
Cardiac hypertrophy
HL-1 cardiomyocytes
title SGK1-Sensitive Regulation of Cyclin-Dependent Kinase Inhibitor 1B (p27) in Cardiomyocyte Hypertrophy
title_full SGK1-Sensitive Regulation of Cyclin-Dependent Kinase Inhibitor 1B (p27) in Cardiomyocyte Hypertrophy
title_fullStr SGK1-Sensitive Regulation of Cyclin-Dependent Kinase Inhibitor 1B (p27) in Cardiomyocyte Hypertrophy
title_full_unstemmed SGK1-Sensitive Regulation of Cyclin-Dependent Kinase Inhibitor 1B (p27) in Cardiomyocyte Hypertrophy
title_short SGK1-Sensitive Regulation of Cyclin-Dependent Kinase Inhibitor 1B (p27) in Cardiomyocyte Hypertrophy
title_sort sgk1 sensitive regulation of cyclin dependent kinase inhibitor 1b p27 in cardiomyocyte hypertrophy
topic p27
Acta1
Isoproterenol
SGK1
Cardiac hypertrophy
HL-1 cardiomyocytes
url http://www.karger.com/Article/FullText/430380
work_keys_str_mv AT jakobvoelkl sgk1sensitiveregulationofcyclindependentkinaseinhibitor1bp27incardiomyocytehypertrophy
AT tatsianacastor sgk1sensitiveregulationofcyclindependentkinaseinhibitor1bp27incardiomyocytehypertrophy
AT katharinamusculus sgk1sensitiveregulationofcyclindependentkinaseinhibitor1bp27incardiomyocytehypertrophy
AT robertviereck sgk1sensitiveregulationofcyclindependentkinaseinhibitor1bp27incardiomyocytehypertrophy
AT sobujmia sgk1sensitiveregulationofcyclindependentkinaseinhibitor1bp27incardiomyocytehypertrophy
AT martinafeger sgk1sensitiveregulationofcyclindependentkinaseinhibitor1bp27incardiomyocytehypertrophy
AT ioanaalesutan sgk1sensitiveregulationofcyclindependentkinaseinhibitor1bp27incardiomyocytehypertrophy
AT florianlang sgk1sensitiveregulationofcyclindependentkinaseinhibitor1bp27incardiomyocytehypertrophy